...Toronto spinout AmacaTheraAmacaThera Inc. raised C$10.3 million ($8.1 million) in a series A round led by Lumira Ventures...

...$17M series B roundIterion Therapeutics Inc. raised $17 million in a series B financing led by Lumira Ventures...

...eventual aspirations is to access the public markets.Besides Allogene and the undisclosed leader, the group includes Lumira Ventures...
...Research Institute, University of TorontoCorporate partners: Allogene Inc.Number of employees: 35Funds raised: $91 millionInvestors: Allogene, Lumira Ventures...

...Ltd. (Tokyo:2395) plus new investors Osage University Partners, CAM Capital, Surveyor, Eventide Asset Management, Cormorant, Lumira Ventures...

...compound also has potential against hepatitis D virus (HDV), which requires HBV for its replication. Lumira Ventures...
...Delos' Henry Chen will join Antios' board. Antios Therapeutics Inc., Atlanta, Ga. Mark Zipkin Antios Therapeutics Inc. Domain Associates Lumira Ventures Hepatitis...

...compound also has potential against hepatitis D virus (HDV), which requires HBV for its replication. Lumira Ventures...
...Nicole Vitullo, CAM Capital's Scott Morenstein and Delos' Henry Chen will join Antios' board. Mark Zipkin Domain Associates Lumira Ventures Hepatitis...